KCNK5 and myeloid sarcoma: Following the functional studies that showed a specific up-regulation in Kv1.3 current responses in MS, we went on to assess the expression levels of all potassium-channel gene products reported to be expressed in human T cells, namely, Kv1.3, KCa3.1 and TASK-2 in MS patients and control subjects.